氧化应激诱导剂在癌症治疗中:临床前和临床证据
Zohra Nausheen Nizami1, Hanan E Aburawi1, Abdelhabib Semlali2
1Department of Biology, College of Science, United Arab Emirates University, Al Ain PO Box 15551, United Arab Emirates.
Antioxidants (Basel, Switzerland)
|June 28, 2023
概括
亲氧化药物,包括植物化学品,诱导反应性氧物种 (ROS) 抵抗癌症. 本综述探讨了诱导ROS的抗癌药物及其治疗潜力的机制.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
背景情况:
- 反应性氧物种 (ROS) 对细胞过程至关重要,但在高水平时会诱导氧化应激.
- 癌细胞操纵氧化还原稳定,创造了可被亲氧化疗法利用的脆弱性.
- 升高的ROS水平可以触发癌细胞死亡,形成治疗策略的基础.
研究的目的:
- 审查具有特征抗癌潜力的亲氧化药物.
- 专注于植物化学物质,它们的ROS诱导机制,以及下游抗癌效应.
- 突出利用癌细胞对ROS的脆弱性的治疗策略.
主要方法:
- 关于亲氧化药物及其抗癌机制的文献综述.
- 对诱导ROS的植物化学物质和小分子的分析.
- 检查ROS诱导与抗癌效应之间的联系.
主要成果:
- 已经确立的化疗药物,如西斯普拉丁和多克索鲁比辛,利用ROS诱导.
- 许多植物化学物质和小分子通过ROS生成表现出抗癌活性.
- ROS诱导是各种抗癌药物的常见机制.
结论:
- 亲氧化药物是癌症治疗中的一个有前途的策略.
- 植物化学物质是新型ROS诱导抗癌剂的重要来源.
- 用亲氧化剂向癌细胞的氧化还原平衡需要进一步研究.
相关概念视频
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


